Bright Minds Biosciences (TSE:DRUG)
:DRUG
Bright Minds Biosciences (DRUG) Ownership Overview
1.03% Insiders
2.59%
Mutual Funds
39.93% Other Institutional Investors
3.56% ETFs
52.89% Public Companies and
Individual Investors
The ownership structure of Bright Minds Biosciences (TSE:DRUG) stock is a mix of institutional, retail, and individual investors. Approximately 46.08% of the company’s stock is owned by Institutional Investors, 1.03% is owned by Insiders, and 52.89% is owned by Public Companies and Individual Investors.
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 449,290 | Institution | 4.59% | 32,879,042 | |
| 269,641 | Institution | 2.76% | 19,732,328 | |
| 243,080 | Institution | 2.48% | 17,788,594 | |
| 206,427 | Institution | 2.11% | 15,106,328 | |
| 103,013 | Institution | 1.05% | 7,538,491 | |
| 57,600 | Insider | 0.59% | 4,215,168 | |
| 52,730 | Institution | 0.54% | 3,858,781 | |
| 52,270 | Institution | 0.53% | 3,825,119 | |
| 38,109 | Insider | 0.39% | 2,788,817 | |
| 30,847 | Institution | 0.32% | 2,257,383 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 103,013 | Institution | 1.05% | 7,538,491 | |
| 52,730 | Institution | 0.54% | 3,858,781 | |
| 30,847 | Institution | 0.32% | 2,257,383 | |
| 27,024 | Institution | 0.28% | 1,977,616 | |
| 12,918 | Institution | 0.13% | 945,339 | |
| 6,391 | Institution | 0.07% | 467,693 | |
| 5,987 | Institution | 0.06% | 438,129 | |
| 4,990 | Institution | 0.05% | 365,168 | |
| 2,246 | Institution | 0.02% | 164,362 | |
| 1,700 | Institution | 0.02% | 124,406 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 165,836 | Institution | 1.69% | 12,157,437 | |
| 57,123 | Institution | 0.58% | 4,187,687 | |
| 17,593 | Institution | 0.18% | 1,289,743 | |
| 12,613 | Institution | 0.13% | 924,659 | |
| 7,452 | Institution | 0.08% | 552,193 | |
| 3,669 | Institution | 0.04% | 268,974 | |
| 3,254 | Institution | 0.03% | 241,121 | |
| 2,716 | Institution | 0.03% | 199,110 | |
| 1,989 | Institution | 0.02% | 145,814 | |
| 666 | Institution | <0.01% | 49,352 |
FAQ
Who Owns Bright Minds Biosciences (TSE:DRUG)?
According to the latest TipRanks data, approximately 39.93% of the company's stock is held by institutional investors, 1.03% is held by insiders, and 52.89% is held by retail investors.
What percentage of Bright Minds Biosciences (TSE:DRUG) stock is held by institutional investors?
According to the latest TipRanks data, approximately 39.93% of Bright Minds Biosciences (TSE:DRUG) stock is held by institutional investors.
What percentage of Bright Minds Biosciences (TSE:DRUG) stock is held by retail investors?
According to the latest TipRanks data, approximately 52.89% of Bright Minds Biosciences (TSE:DRUG) stock is held by retail investors.
Who owns the most shares of Bright Minds Biosciences (TSE:DRUG)?
Joseph Edelman owns the most shares of Bright Minds Biosciences (TSE:DRUG).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.